Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2008 | 03-2007 | 03-2006 | 03-2005 | 03-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,603 | -3,414 | -673 | 1,811 | 1,001 |
| Depreciation Amortization | 740 | 392 | 458 | 417 | 450 |
| Income taxes - deferred | N/A | 1,266 | -237 | -805 | -224 |
| Accounts receivable | 760 | 858 | 512 | -803 | -320 |
| Accounts payable and accrued liabilities | -820 | 767 | -681 | 694 | -239 |
| Other Working Capital | 2,045 | 1,370 | 1,529 | -3,520 | 506 |
| Other Operating Activity | 1,621 | -1,526 | 209 | 78 | 545 |
| Operating Cash Flow | $-4,257 | $-287 | $1,117 | $-2,128 | $1,719 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 4,032 | -85 | -175 | -351 | -487 |
| Purchase Sale Intangibles | N/A | N/A | -210 | -112 | -146 |
| Other Investing Activity | -355 | -177 | -210 | -112 | -146 |
| Investing Cash Flow | $3,677 | $-262 | $-385 | $-463 | $-633 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,750 | N/A | N/A | N/A | N/A |
| Debt Issued | 750 | N/A | N/A | N/A | N/A |
| Debt Repayment | -68 | -11 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 29 | 60 | 26 |
| Other Financing Activity | -1,159 | 0 | -3 | 0 | 0 |
| Financing Cash Flow | $2,273 | $-11 | $26 | $60 | $26 |
| Beginning Cash Position | 375 | 935 | 177 | 2,708 | 1,596 |
| End Cash Position | 2,068 | 375 | 935 | 177 | 2,708 |
| Net Cash Flow | $1,693 | $-560 | $758 | $-2,531 | $1,112 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,257 | -287 | 1,117 | -2,128 | 1,719 |
| Capital Expenditure | -161 | -85 | -175 | -351 | -487 |
| Free Cash Flow | -4,418 | -372 | 942 | -2,479 | 1,232 |